Wholesale of pharmaceutical and medical goods
LUMIBIRD MEDICAL NORDICS AS
Revenue 2024
NOK 8.4m
Operating profit
NOK −444,000
Equity
NOK 2.2m
Incorporated
1997
Share capital
NOK 100,000
Key figures · 2024
Current ratio
3.80
Equity ratio
74.5%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -5.3% | |
| Net margin (%%) | -4.5% | |
| Return on assets (%%) | -14.8% | |
| Likviditet | ||
| Current ratio | 3.80 | |
| Working capital | 2.1m | |
| Soliditet | ||
| Equity ratio (%%) | 74.5% | |
| Debt-to-equity ratio | 0.34 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.